432 papers found
Refreshing results…
Figure S12
Figure S3
Abstract 4702: Effects of smoking on the molecular pathology of urinary bladder cancer and its prognostic importance
Abstract 4801: Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer
Abstract 4892: Epigenetic reprogramming associated with melanocyte malignant transformation induced by sustained stress condition
Hypomethylation of a LINE-1 Promoter Activates an Alternate Transcript of the MET Oncogene in Bladders with Cancer
Methylation-Sensitive Single-Molecule Analysis of Chromatin Structure
Tissue Inhibitor of Metalloproteinase 1 Expression Associated with Gene Demethylation Confers Anoikis Resistance in Early Phases of Melanocyte Malignant Transformation1
Tissue Inhibitor of Metalloproteinase 1 Expression Associated with Gene Demethylation Confers Anoikis Resistance in Early Phases of Melanocyte Malignant Transformation 1
Selective Anchoring of DNA Methyltransferases 3A and 3B to Nucleosomes Containing Methylated DNA▿
OPINION Rethinking how DNA methylation patterns are maintained
Epigenetics in cancer
Emergency Department utilisation: A natural experiment
The tumor suppressor microRNA-101 becomes an epigenetic player by targeting the Polycomb group protein EZH2 in cancer
Analysis of individual remodeled nucleosomes reveals decreased histone–DNA contacts created by hSWI/SNF
MicroRNAs: critical mediators of differentiation, development and disease
DZNep Is a Global Histone Methylation Inhibitor that Reactivates Developmental Genes Not Silenced by DNA Methylation
The Putative Tumor Suppressor microRNA-101 Modulates the Cancer Epigenome by Repressing the Polycomb Group Protein EZH2
Activation of p16 gene silenced by DNA methylation in cancer cells by phosphoramidate derivatives of 2’-deoxyzebularine
Molecular targets and targeted therapies in bladder cancer Management
Missing publications? Read more about our data sources.